Education September 26, 2026

Charcot foot and diabetes: what it is, how to recognize it, and what can be done

Charcot foot is a devastating but treatable complication of diabetic neuropathy. Bones weaken, fracture, and the foot can collapse — often without pain. Early recognition changes the outcome dramatically.

Medically reviewed by Professor Cheng Wang, MD September 26, 2026

Charcot foot — known medically as Charcot neuroarthropathy (CN) — is one of the most serious and underdiagnosed complications of diabetes. It occurs when severe neuropathy allows bones in the foot to weaken, fracture, and dislocate during ordinary walking, often without the patient feeling any pain. Left untreated, the foot can collapse into a shape called a "rocker-bottom" deformity that creates pressure points almost impossible to protect, leading to ulcers, infection, and potential amputation. This guide explains what Charcot foot is, how to recognize it, how it progresses, and what treatment options exist. It is educational information, not medical advice — always consult a qualified physician about your own situation.

What is Charcot foot?

Charcot foot is a progressive condition where the bones and joints of the foot weaken and break apart due to nerve damage. In diabetes, long-standing peripheral neuropathy eliminates protective sensation — the patient cannot feel the micro-fractures that accumulate with every step. The body responds with intense inflammation, which paradoxically accelerates bone destruction by increasing blood flow and activating osteoclasts (cells that break down bone).

The result is a destructive cycle: neuropathy removes pain signals, continued walking causes fractures, inflammation weakens more bone, and the foot gradually deforms. Charcot foot affects an estimated 0.1-0.9% of all diabetes patients, but the true incidence is likely higher because early cases are frequently misdiagnosed as gout, cellulitis, deep vein thrombosis, or simple sprains.

How does Charcot foot relate to diabetes?

Charcot foot and diabetes are directly connected through neuropathy. The condition almost exclusively occurs in people with significant peripheral nerve damage — and diabetes is the leading cause of peripheral neuropathy worldwide. Several factors in diabetes create the conditions for Charcot foot:

  • Peripheral neuropathy — the fundamental prerequisite. Without sensation, the patient cannot detect the progressive bone destruction happening inside their foot
  • Autonomic neuropathy — damages the nerves controlling blood vessel tone, causing increased blood flow to the foot (a warm, well-perfused foot). This hyperemia contributes to bone weakening
  • Metabolic bone changes — chronic hyperglycemia, vitamin D deficiency, and diabetic kidney disease all reduce bone mineral density, making fractures more likely
  • Motor neuropathy — alters foot mechanics by weakening intrinsic muscles, changing how forces distribute during walking and concentrating stress on vulnerable areas

Most patients who develop Charcot foot have had diabetes for 10 or more years and have established neuropathy. Both type 1 and type 2 diabetes carry risk, though type 2 accounts for the majority of cases simply because it is far more prevalent.

What are the symptoms of Charcot foot?

The earliest signs of Charcot foot are easy to miss — and easy to confuse with other conditions. Key symptoms to watch for:

  • Sudden swelling — one foot becomes noticeably larger than the other, often without any recalled injury. The swelling can develop over hours to days
  • Warmth — the affected foot feels significantly warmer than the other foot. A temperature difference of 2°C (3.6°F) or more between feet is a clinical red flag
  • Redness — the skin over the midfoot or ankle area becomes red or flushed, resembling an infection
  • Minimal or no pain — this is the defining paradox. Despite bones fracturing and joints dislocating, the patient may feel only mild discomfort or nothing at all. Patients who do feel pain describe a deep ache rather than sharp fracture pain
  • Changes in foot shape — as the condition progresses, the arch may flatten, the midfoot may bulge downward, or the ankle may shift to one side
  • Instability — the foot feels "loose" or unstable during walking, as if the bones are not holding together properly

The most dangerous aspect of Charcot foot is its mimicry. The acute phase looks almost identical to cellulitis or an infected wound — red, hot, swollen foot — and many patients receive antibiotics for a misdiagnosed infection while the actual bone destruction continues unchecked. Any diabetic patient with a unilaterally swollen, warm foot and intact skin should be evaluated for Charcot foot, not just infection.

What are the stages of Charcot foot?

Charcot foot progresses through three recognized stages, classified by the Eichenholtz system. Understanding these stages helps explain why early detection matters so much:

  • Stage 1 — Development (acute/active phase). The foot is red, hot, and swollen. X-rays may show bone fragmentation, joint subluxation, or early fractures. This is when bone destruction is most rapid. The foot temperature is significantly elevated compared to the other side. This stage can last weeks to months
  • Stage 2 — Coalescence (subacute phase). Inflammation begins to subside. Swelling and warmth decrease. The body starts attempting to repair the damage — new bone formation begins, fracture fragments start consolidating. X-rays show early bone healing and absorption of debris. The foot temperature difference narrows
  • Stage 3 — Reconstruction (chronic/healed phase). Inflammation has resolved. The bones have consolidated into their new positions — which may or may not resemble the original anatomy. The foot shape is now fixed. If significant deformity occurred during stages 1-2, the patient is left with a permanently altered foot that requires lifelong protective footwear

The critical window is stage 1. If Charcot foot is recognized and treated during the acute phase — before significant deformity develops — the foot can often be stabilized in a near-normal shape. Once deformity is established in stage 3, treatment shifts from prevention to management.

How is Charcot foot diagnosed?

Diagnosing Charcot foot requires clinical suspicion and imaging. The process typically includes:

  • Clinical examination — comparing both feet for temperature difference (using an infrared thermometer or the back of the hand), swelling asymmetry, and visible deformity. A warm, swollen, neuropathic foot with intact skin is Charcot until proven otherwise
  • X-rays — the first-line imaging study. May show fractures, joint dislocations, bone fragmentation, or the classic "bag of bones" appearance in advanced cases. However, early Charcot can look normal on plain X-rays
  • MRI — more sensitive than X-rays for detecting early bone marrow edema (the earliest sign of Charcot activity). MRI can identify Charcot foot before fractures become visible on X-ray, and helps distinguish it from osteomyelitis
  • Bone scan — a nuclear medicine study that shows areas of increased bone turnover. Useful when MRI is not available, though less specific
  • Blood tests — inflammatory markers (ESR, CRP) may be elevated but are not specific. Blood tests help rule out infection rather than confirm Charcot foot

The most common diagnostic error is treating a Charcot foot as an infection. Both present with a red, hot, swollen foot — but Charcot foot typically has intact skin, no fever, normal or mildly elevated white blood cell count, and a temperature difference confined to the foot. If antibiotics do not resolve the swelling, Charcot foot should be strongly suspected.

What are the treatment options for Charcot foot?

Charcot foot treatment depends on the stage at diagnosis and the degree of deformity. The primary goals are: stop the bone destruction, stabilize the foot, prevent ulceration, and avoid amputation.

Non-surgical treatment

Most Charcot foot cases are initially managed without surgery:

  • Total contact casting (TCC) — the gold standard for acute Charcot foot. A custom-molded cast immobilizes the foot and redistributes pressure evenly, preventing further fractures while allowing existing ones to heal. The cast is changed every 1-2 weeks as swelling reduces. Treatment duration averages 3-6 months but can extend to 12 months or longer
  • Removable cast walkers (CROW) — Charcot Restraint Orthotic Walker. Used after TCC when the acute phase resolves, or as an alternative when TCC is not practical. Less effective than TCC because patients can remove them
  • Strict non-weight-bearing — in severe acute cases, complete offloading with crutches or wheelchair may be necessary to stop the destructive cycle
  • Monitoring — serial temperature measurements and X-rays every 4-6 weeks to track progression from stage 1 through stage 2 to stage 3. The foot is considered "quiescent" when the temperature difference between feet drops below 2°C
  • Custom therapeutic footwear — once the foot reaches stage 3, specially designed shoes with custom insoles accommodate the altered foot shape and protect against ulceration

Surgical treatment

Surgery for Charcot foot is considered when conservative treatment fails or when deformity creates an unacceptable risk of ulceration and amputation:

  • Exostectomy — removing bony prominences (especially the rocker-bottom bulge on the sole) that create pressure points and cause ulcers. A relatively straightforward procedure that can prevent breakdown without reconstructing the entire foot
  • Arthrodesis (fusion) — fusing collapsed or unstable joints using internal fixation (plates, screws, or specialized beams). This is the definitive reconstructive procedure for significant Charcot deformity, aiming to create a stable, plantigrade (flat on the ground) foot
  • External fixation — using an external frame (such as an Ilizarov or Taylor spatial frame) to gradually correct deformity and stabilize the foot. Often used for severe deformities that cannot be corrected in a single surgical step
  • Achilles tendon lengthening — tight Achilles tendons increase forefoot pressure and contribute to midfoot collapse. Lengthening the tendon reduces this force and is frequently performed alongside other procedures

Surgery on Charcot feet carries higher complication rates than in normal bone — the weakened bone may not hold hardware well, infection risk is elevated, and healing takes longer. But for patients facing amputation due to severe deformity and recurrent ulceration, reconstructive surgery can save the limb.

Can Charcot foot lead to amputation?

Yes — Charcot foot is a significant pathway to amputation in diabetes, though the mechanism is indirect:

  • Severe deformity creates pressure points that standard shoes cannot protect
  • These pressure points develop ulcers — and ulcers on a Charcot foot are notoriously difficult to heal because the underlying bone architecture is abnormal
  • Chronic ulcers become infected, and infection in deformed bone is harder to treat than in normal anatomy
  • If infection cannot be controlled or the foot becomes non-functional, amputation may become the safest option

Studies report amputation rates of 2.7-25% in Charcot foot patients, with the wide range reflecting differences in how early the condition was detected and how aggressively it was treated. The patients at highest risk are those whose Charcot foot was misdiagnosed during the acute phase, allowing severe deformity to develop before treatment began.

Living with Charcot foot: long-term management

Charcot foot is a lifelong condition. Even after the acute phase resolves and the foot stabilizes, ongoing vigilance is essential:

  • Daily foot inspection — check for new redness, warmth, swelling, or skin breakdown. The other foot is also at risk (bilateral Charcot occurs in up to 30% of cases)
  • Custom footwear — wearing prescribed therapeutic shoes at all times, including indoors. Standard shoes almost never accommodate a post-Charcot foot shape adequately
  • Regular specialist follow-up — monitoring for recurrence, contralateral involvement, and secondary ulceration at least every 3-6 months
  • Blood sugar management — maintaining glycemic control slows neuropathy progression and supports bone health
  • Activity modification — understanding which activities are safe and which create dangerous stress on the reconstructed foot

When to seek specialist help

If you have diabetes and neuropathy, seek immediate evaluation for any of these:

  • One foot is suddenly more swollen than the other
  • One foot feels warmer than the other to touch
  • Your foot shape appears to be changing — flattening arch, widening, or bony prominence you have not noticed before
  • You have a wound on the bottom of your foot that keeps recurring despite proper care
  • You have been told you need amputation for a Charcot foot deformity and want a second opinion

Charcot foot is a condition where timing determines outcomes. A foot evaluated and casted during the acute phase may heal with minimal deformity. The same foot left untreated for months may collapse to a point where only major reconstructive surgery — or amputation — remains.

Can advanced care help a Charcot foot?

Chinese specialist centers with multidisciplinary diabetic foot teams offer comprehensive Charcot foot management including precision imaging, total contact casting, and surgical reconstruction when needed. For patients with established deformity, ulceration on a Charcot foot, or a recommendation for amputation, a specialist evaluation may identify treatment pathways that were not available locally.

DFU Care China provides free remote evaluations for international patients with Charcot foot complications. Share your imaging and medical records via WhatsApp for an honest assessment of whether specialized treatment could help — including whether your foot is suitable for reconstruction, or whether conservative management is the better path.

This article is for educational purposes. Every patient's situation is different. The information here is general guidance, not a substitute for professional medical advice. Always consult a qualified healthcare professional about your specific case.

References

  1. Rogers LC et al. The Charcot Foot in Diabetes. Diabetes Care. 2011;34(9):2123-2129.
  2. Rosenbaum AJ, DiPreta JA. Classifications in Brief: Eichenholtz Classification of Charcot Arthropathy. Clin Orthop Relat Res. 2015;473(3):1168-1171.
  3. Milne TE et al. Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot neuro-arthropathy. J Foot Ankle Res. 2013;6:30.
  4. Game FL et al. IWGDF Guidance on use of interventions to enhance healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev. 2016;32(Suppl 1):75-83.
  5. Wukich DK et al. Surgery for Charcot Neuroarthropathy of the Foot and Ankle. Foot Ankle Int. 2021;42(6):791-801.

← All posts